Swiss National Bank’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,700	Closed	-$205K	–	2780
2022 Q1	$205K	Buy	29,700 +2,200	+8%	+$15.2K	﹤0.01%	2676
2021 Q4	$342K	Buy	27,500 +7,000	+34%	+$87.1K	﹤0.01%	2708
2021 Q3	$641K	Hold	20,500	–	–	﹤0.01%	2542
2021 Q2	$587K	Buy	+20,500	New	+$587K	﹤0.01%	2608